Katrin Roth

No ORCID on file · 3 papers in corpus
rct 2024
BMC women's health ·doi:10.1186/s12905-024-03188-8

BACKGROUND: The SCHUMANN study evaluated the efficacy and safety of the selective P2 × 3 antagonist eliapixant in patients with endometriosis-associated pelvic pain (EAPP). METHODS: SCHUMANN was a randomized, placebo- and active comparator…

article 2018
Contraception ·doi:10.1016/j.contraception.2018.08.001

ObjectiveTo compare the effects of chlormadinone acetate (CMA), dienogest (DNG) and drospirenone (DRSP) on prostaglandin biosynthesis in a human endometrial explants model.Study designHuman endometrial explants obtained by aspiration curett…

article 2018
·doi:10.1055/s-0038-1671290

To compare the effects of chlormadinone acetate (CMA), dienogest (DNG) and drospirenone (DRSP) on prostaglandin biosynthesis in a human endometrial explants model.